Cost-Effectiveness of Cobas® EGFR Mutation Test Versus Sanger Sequencing in the Treatment of Locally Advanced or Metastatic NSCLC: A Payer Perspective in the United Kingdom

Saved in:
Bibliographic Details
Published in:Value in health 2013-11, Vol.16 (7), p.A410-A410
Main Authors: Towse, A, Gavaghan, M, Strunz-McKendry, T, Garfield, S, Poulios, N
Format: Article
Language:English
Subjects:
Internal Medicine
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2013.08.501